Early switching to intramuscular anti-HBs Immunoglobulins (Igantibe™) after liver transplantation: feasibility, efficacy, and safety

Authors
Publication date
1 January 2011
Publisher
'Wiley'
Doi

    Abstract

    We present the results of a single-center trial on early switching from i.v to i.m.anti HBs immunoglobulins (HBG) after liver transplantation

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Archivio della Ricerca - Università di Pisa

      redirect
      oaioai:arpi.unipi.it:11568/893678
      Last time updated on 09/02/2018